The altered lncRNAs in tumors are expected to be used as diagnostic markers in multiple tumors, such as lncRNA HOTAIR (in breast cancer) [5] and lncRNA MALAT1 in liver cancer, breast cancer, non-lung small cell carcinoma, colon cancer and prostate cancer [6]. This evidence concerns the gene MALAT1 and breast carcinoma.